1. Home
  2. BDTX vs GHG Comparison

BDTX vs GHG Comparison

Compare BDTX & GHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Black Diamond Therapeutics Inc.

BDTX

Black Diamond Therapeutics Inc.

N/A

Current Price

$1.38

Market Cap

104.0M

Sector

Health Care

ML Signal

N/A

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

N/A

Current Price

$0.97

Market Cap

101.9M

ML Signal

N/A

Company Overview

Basic Information
Metric
BDTX
GHG
Founded
2014
2004
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
104.0M
101.9M
IPO Year
2020
2017

Fundamental Metrics

Financial Performance
Metric
BDTX
GHG
Price
$1.38
$0.97
Analyst Decision
Buy
Analyst Count
8
0
Target Price
★ $11.00
N/A
AVG Volume (30 Days)
★ 766.3K
36.2K
Earning Date
11-10-2026
12-22-2026
Dividend Yield
N/A
★ 5.83%
EPS Growth
★ 130.71
N/A
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$56.17
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$5.76
Revenue Growth
N/A
N/A
52 Week Low
$1.39
$0.91
52 Week High
$3.97
$1.99

Technical Indicators

Market Signals
Indicator
BDTX
GHG
Relative Strength Index (RSI) 34.73 45.90
Support Level N/A $0.92
Resistance Level $1.94 $1.13
Average True Range (ATR) 0.14 0.05
MACD -0.04 0.00
Stochastic Oscillator 0.84 31.86

Price Performance

Historical Comparison
BDTX
GHG

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The foundation of companies has been built upon a deep understanding of cancer genetics, onco-protein structure and function, and medicinal chemistry. Its clinical-stage program, silevertinib (formerly BDTX-1535), a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor, is currently being studied in a Phase 2 clinical trial in patients with epidermal growth factor receptor mutant (EGFRm) non-small cell lung cancer (NSCLC). The Company manages its operations as a single operating segment and single reportable segment.

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The Group reports its financial results in two operating segments: Hotel Business, which consists of leased-and-operated hotels and franchised-and-managed hotels operating under the hotel related brand, and Restaurant Business, which consists of leased-and-operated restaurants and franchised-and-managed restaurants operating under the brands of Da Niang and Bellagio. It derives maximum revenue from Hotel Business segment. It operates solely in China and generates all its revenue from China itself.

Share on Social Networks: